Skip to main content
Log in

PS11 - 1. Longitudinal eGFR trajectories in patients with type 2 diabetes

  • Published:
Nederlands Tijdschrift voor Diabetologie Aims and scope

Abstract

The decline in glomerular filtration rate (GFR) is used as outcome parameter to establish drug efficacy in clinical trials of renal disease progression. For analyzing and interpretation of trial results it is assumed that renal function declines linearly over time. However, a recent study in Afro- Americans with hypertensive nephrosclerosis documented that 42% of patients exhibit > 90% probability of non-linear GFR trajectory or prolonged period of nonprogression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Misghina Weldegiorgis.

Additional information

Parallel session 11. 14:00-15:00 diabetes, microvascular complications and cancer (nsdeg)

1 Department of Clinical Pharmacology, UMCG, Groningen, Groningen, The Netherlands, 2University of Utah, Salt Lake City UT, USA, 2 Cleveland Clinic, Cleveland, OH, USA, 3 Steno Diabetes Center, Gentofte, Denmark. E-mail: m.weldegiorgis@umcg.nl

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weldegiorgis, M., de Zeeuw, D., Greene, T. et al. PS11 - 1. Longitudinal eGFR trajectories in patients with type 2 diabetes. NED. TIJDSCHR. DIABET. 11, 162 (2013). https://doi.org/10.1007/s12467-013-0107-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12467-013-0107-6

Keywords

Navigation